![David Lebwohl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Lebwohl
Directeur Technique/Scientifique/R&D chez
INTELLIA THERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
David Lebwohl occupe le poste de Chief Medical Officer & Executive Vice President chez Intellia Therapeutics, Inc. Il est également membre de l'American Society of Clinical Oncology. Dans sa carrière antérieure, le Dr Lebwohl a occupé le poste de Chief Medical Officer de Semma Therapeutics, Inc. et de Senior Vice President de Novartis Pharmaceuticals Corp. Le Dr Lebwohl a obtenu un doctorat de l'université de Yale et un diplôme de premier cycle du Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 158 775 ( 0,11% ) | 2 M $ | 31/05/2026 |
Postes actifs de David Lebwohl
| Sociétés | Poste | Début |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 30/04/2020 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Anciens postes connus de David Lebwohl
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Directeur Technique/Scientifique/R&D | - |
Formation de David Lebwohl
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
